The Motley Fool
23 Sept 2026, 02:04 UTC · 2h ago
Verdict
Headline takes no side. We score AMGN +0.50 across four claims — strongly bullish.
+0.50strongly bullish
More positive than 66% of ticker scores this week
What the story claims
4 claims · scored −1 bearish … +1 bullish · 0 new · 4 priced in
The Invesco Nasdaq Biotechnology ETF (IBBQ) has a significantly higher one-year return compared to the iShares U.S. Healthcare ETF (IYH).
Priced inanalysis of trailing 12 month returns
So whatThe higher growth trajectory suggests a shift in investor appetite toward high-beta biotech names over broad healthcare stability for the next quarter.
More positive than 63% of claims this week
Continue reading
5 related stories
Scored by the NIS engine · methodology.
The iShares U.S. Healthcare ETF (IYH) maintains a concentrated top-three holding weight of 32.27% across Eli Lilly, Johnson & Johnson, and Abbvie.
Priced indescription of current fund holdings
More positive than 51% of claims this week
IBBQ charges an expense ratio of 0.19%, which is nearly half the 0.37% charged by IYH.
Priced incomparison of standing fund fees
So whatThe 18bps cost advantage provides a marginal boost to net returns for long-term holders through 2027.
More positive than 42% of claims this week
The iShares U.S. Healthcare ETF (IYH) offers a trailing 12-month dividend yield of 1.1% compared to IBBQ's 0.7%.
Priced inanalysis of trailing 12-month distributions
So whatThe 40bps yield gap makes IYH more attractive for income-focused portfolios during periods of high volatility.
Near neutral — 98% of claims this week are stronger
Which stocks this story touches
More positive than 66% of ticker scores this week
Listed as a top holding in a high-growth biotech ETF and recommended by The Motley Fool.
More positive than 62% of ticker scores this week
Listed as a top holding in a high-growth biotech ETF and recommended by The Motley Fool.
More positive than 62% of ticker scores this week
Listed as a top holding in a high-growth biotech ETF and recommended by The Motley Fool.
More positive than 52% of ticker scores this week
Listed as a top holding in a healthcare ETF with a slight positive price movement.
More positive than 52% of ticker scores this week
Listed as a top holding in a healthcare ETF and recommended by The Motley Fool.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
—
AMGN hasn't traded since this ran. Last close $410.24 (Sep 22); the reaction starts at the next open.
AMGN chart →